Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela M Lam

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Future Medicinal Chemistry|March 24, 2011
Nucleoside analog inhibitors of hepatitis C viral replication: recent advances, challenges and trendsPhillip A Furman, Angela M Lam, Eisuke Murakami
ACS Medicinal Chemistry Letters|October 16, 2020
<i>P</i>450s <i>u</i>nder <i>Re</i>striction (PURE) Screen Using HepaRG and Primary Human Hepatocytes for Discovery of Novel HBV AntiviralsGeorge D Hartman, Scott D Kuduk, Christine Espiritu, et al.
Journal of Virology|November 30, 2022
Pregenomic RNA Launch Hepatitis B Virus Replication System Facilitates the Mechanistic Study of Antiviral Agents and Drug-Resistant Variants on Covalently Closed Circular DNA SynthesisQiong Zhao, Jinhong Chang, Rene Rijnbrand, et al.
Journal of Virology|September 30, 2011
Hepatitis C virus nucleotide inhibitors PSI-352938 and PSI-353661 exhibit a novel mechanism of resistance requiring multiple mutations within replicon RNAAngela M Lam, Christine Espiritu, Shalini Bansal, et al.
Gastroenterology|October 29, 2017
Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV InfectionKlaus Klumpp, Takashi Shimada, Lena Allweiss, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2019
SAR studies in the sulfonyl carboxamide class of HBV capsid assembly modulatorsScott D Kuduk, Angela M Lam, Christine Espiritu, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2012
Inhibition of hepatitis C virus NS5A by fluoro-olefin based γ-turn mimeticsWonsuk Chang, Ralph T Mosley, Shalini Bansal, et al.
Antimicrobial Agents and Chemotherapy|June 1, 2017
Hepatitis B Virus Capsid Assembly Modulators, but Not Nucleoside Analogs, Inhibit the Production of Extracellular Pregenomic RNA and Spliced RNA VariantsAngela M Lam, Suping Ren, Christine Espiritu, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 2021
Oxadiazepinone HBV capsid assembly modulatorsScott D Kuduk, Bart Stoops, Angela M Lam, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2023
Di-fluoro azepane HBV capsid assembly modulatorsLindsey G DeRatt, Bart Stoops, Paul Shaffer, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Future Medicinal Chemistry|March 24, 2011
Nucleoside analog inhibitors of hepatitis C viral replication: recent advances, challenges and trendsPhillip A Furman, Angela M Lam, Eisuke Murakami
ACS Medicinal Chemistry Letters|October 16, 2020
<i>P</i>450s <i>u</i>nder <i>Re</i>striction (PURE) Screen Using HepaRG and Primary Human Hepatocytes for Discovery of Novel HBV AntiviralsGeorge D Hartman, Scott D Kuduk, Christine Espiritu, et al.
Journal of Virology|November 30, 2022
Pregenomic RNA Launch Hepatitis B Virus Replication System Facilitates the Mechanistic Study of Antiviral Agents and Drug-Resistant Variants on Covalently Closed Circular DNA SynthesisQiong Zhao, Jinhong Chang, Rene Rijnbrand, et al.
Journal of Virology|September 30, 2011
Hepatitis C virus nucleotide inhibitors PSI-352938 and PSI-353661 exhibit a novel mechanism of resistance requiring multiple mutations within replicon RNAAngela M Lam, Christine Espiritu, Shalini Bansal, et al.
Gastroenterology|October 29, 2017
Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV InfectionKlaus Klumpp, Takashi Shimada, Lena Allweiss, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2019
SAR studies in the sulfonyl carboxamide class of HBV capsid assembly modulatorsScott D Kuduk, Angela M Lam, Christine Espiritu, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2012
Inhibition of hepatitis C virus NS5A by fluoro-olefin based γ-turn mimeticsWonsuk Chang, Ralph T Mosley, Shalini Bansal, et al.
Antimicrobial Agents and Chemotherapy|June 1, 2017
Hepatitis B Virus Capsid Assembly Modulators, but Not Nucleoside Analogs, Inhibit the Production of Extracellular Pregenomic RNA and Spliced RNA VariantsAngela M Lam, Suping Ren, Christine Espiritu, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 2021
Oxadiazepinone HBV capsid assembly modulatorsScott D Kuduk, Bart Stoops, Angela M Lam, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2023
Di-fluoro azepane HBV capsid assembly modulatorsLindsey G DeRatt, Bart Stoops, Paul Shaffer, et al.
Pageof 4